GERON CORP

GERN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2015 FY2014 FY2013 FY2012 FY2011 FY2010 FY2009
Revenue $36.4M $1.2M $1.3M $2.7M $2.4M $3.6M $1.7M
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense $17.8M $16.8M $15.6M $20.4M $23.8M $18.0M $14.3M
Operating Income $-559.0K $-36.3M $-39.0M $-71.8M $-96.1M $-111.2M $-70.2M
Operating Margin -1.5% -3,149.3% -3,036.5% -2,648.9% -3,942.4% -3,120.0% -4,069.2%
Interest Expense
Pretax Income
Income Tax Expense
Net Income $46.0K $-35.7M $-38.4M $-68.9M $-96.9M $-111.4M $-70.2M
Net Margin 0.1% -3,093.7% -2,991.3% -2,542.7% -3,972.6% -3,125.9% -4,066.3%
EPS (Basic) $0.00 $-0.23 $-0.30 $-0.54 $-0.78 $-1.14 $-0.80
EPS (Diluted) $0.00 $-0.23 $-0.30 $-0.54 $-0.78 $-1.14 $-0.80
Shares Outstanding (Basic) 158.0M 153.5M 128.4M 130.2M 131.4M 122.6M
Shares Outstanding (Diluted) 162.7M 153.5M 128.4M 130.2M 131.4M 122.6M
Dividends Per Share
← Newer Page 2 of 2 Older →